Dana Cardin
Faculty Member
Last active: 3/18/2014

Dana B Cardin, MD, MSCI

Official Affiliation: Medicine

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer. Cardin DB, Goff L, Li CI, Shyr Y, Winkler C, DeVore R, Schlabach L, Holloway M, McClanahan P, Meyer K, Grigorieva J, Berlin J, Chan E (2014) Cancer Med 3(3): 572-9
    › Primary publication · 24574334 (PubMed) · PMC4101748 (PubMed Central)
  2. Pancreas cancer on the rise: are we up to the challenge? Cardin DB, Berlin JD (2013) J Natl Cancer Inst 105(22): 1675-6
    › Primary publication · 24203986 (PubMed)
  3. Current treatment options for pancreatic carcinoma. Castellanos E, Berlin J, Cardin DB (2011) Curr Oncol Rep 13(3): 195-205
    › Primary publication · 21491194 (PubMed)
  4. Treatment of early-stage pancreatic cancer. Castellanos EH, Cardin DB, Berlin JD (2011) Oncology (Williston Park) 25(2): 182-9
    › Primary publication · 21456390 (PubMed)
  5. Update on adjuvant trials for pancreatic cancer. Backlund DC, Berlin JD, Parikh AA (2010) Surg Oncol Clin N Am 19(2): 391-409
    › Primary publication · 20159521 (PubMed)

Featured Affiliation

View all affiliations

Contact Information

No address provided
Email

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword

Adult African Americans Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor CA-19-9 Antigen Chemotherapy, Adjuvant Cisplatin Clinical Trials as Topic Combined Modality Therapy Deoxycytidine Disease-Free Survival ErbB Receptors Erlotinib Hydrochloride Female Fluorouracil Humans Male Middle Aged Molecular Targeted Therapy Neoadjuvant Therapy Neoplasm Staging Pancreatic Neoplasms Phenylurea Compounds Positron-Emission Tomography Quinazolines Radiotherapy, Adjuvant Sorafenib Whites